13116-27-3

Basic information

• Product Name: 4-Iodophenylhydrazine
• Synonyms: BUTTPARK 43\57-23;4-IODOPHENYLHYDRAZINE;1-(4-IODOPHENYL)HYDRAZINE;1-(4-Iodophenyl)hydrazine, 95+%;4-IODOPHENYLHYDRAZINE, 95+%;4-IodophenylhydrazineDISC 08/09/02;4-Hydrazinoiodobenzene;4-Iodophenylhydrazine, 95% 1GR
• CAS NO: 13116-27-3
• Molecular Formula: C₆H₇IN₂
• Molecular Weight: 234.04
• Product Categories: Aromatic Hydrazides, Hydrazines, Hydrazones and Oximes;Phenyls & Phenyl-Het;Phenyls & Phenyl-Het;Hydrazines;Nitrogen Compounds;Organic Building Blocks;Building Blocks;Chemical Synthesis;Nitrogen Compounds;Organic Building Blocks
• Mol File: 13116-27-3.mol

Chemical Properties

• Melting Point: 102-106 °C(lit.)
• Boiling Point: 304.8°Cat760mmHg
• Flash Point: 138.1°C
• Appearance: /
• Density: 1.981g/cm³
• Vapor Pressure: 0.000856mmHg at 25°C
• Refractive Index: 1.74
• Storage Temp.: Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
• PKA: 4.91±0.20(Predicted)
• Water Solubility: Insoluble in water.
• Sensitive: Light Sensitive
• BRN: 742475
• CAS DataBase Reference: 4-Iodophenylhydrazine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Iodophenylhydrazine(13116-27-3)
• EPA Substance Registry System: 4-Iodophenylhydrazine(13116-27-3)

Safety Data

• Hazard Codes: Xn,Xi
• Statements: 22-36/37/38-43-40-20/21/22
• Safety Statements: 26-45-36/37/39-24-36/37
• RIDADR: 2811
• WGK Germany: 3
• HazardClass: IRRITANT-HARMFUL, LIGHT SENSITIV
• PackingGroup: III
• Hazardous Substances Data: 13116-27-3(Hazardous Substances Data)

Usage

Chemical Properties

White to orange-brown crystalline powder

InChI:InChI=1/C6H7IN2/c7-5-1-3-6(9-8)4-2-5/h1-4,9H,8H2

Upstream product

• 7772-99-8 stannous chloride 
• 540-37-4 p-aminoiodobenzene 

Downstream Products

• 501-65-5 diphenyl acetylene 
• 613-37-6 4-methoxylbiphenyl 
• 7598-80-3 4-phenylbenzhydrol 
• 914088-80-5 7,8-dihydro-5H-pyrido[3,2-b]azepine-6,9-dione 9-[(4-iodophenyl)hydrazone] 
• 1312761-35-5 2-(1H-indol-3-yl)-N'-(4-iodophenyl)-2-oxoacetohydrazide 

Relevant articles and documents

Homo- and hetero-[3]rotaxanes with two π-systems clasped in a single macrocycle

Here we present the first synthesis of a [3]rotaxane with two dumbbell components threaded through a single γ-cyclodextrin macrocycle. This synthesis is carried out in two steps: first one dumbbell is synthesized threaded through the macrocycle to give a

Bistetrazine-Cyanines as Double-Clicking Fluorogenic Two-Point Binder or Crosslinker Probes

Fluorogenic probes can be used to minimize the background fluorescence of unreacted and nonspecifically adsorbed reagents. The preceding years have brought substantial developments in the design and synthesis of bioorthogonally applicable fluorogenic syst

Smart J-aggregate of cyanine photosensitizer with the ability to target tumor and enhance photodynamic therapy efficacy

Photodynamic therapy (PDT) has been demonstrated to be effective for cancer treatment. Design of photosensitizers (PS) featuring tumor targeting, long excitation wavelengths, and high singlet oxygen quantum yields (Φ(1O2)) is the cru

Studies on a vinyl ruthenium-modified squaraine dye: Multiple visible/near-infrared absorbance switching through dye- and substituent-based redox processes

The bis(vinyl ruthenium)-modified squaraine dye 1 was synthesized by treatment of [RuHCl(CO)(PiPr3)2] with bis(ethynyl)- substituted squaraine 8. Spectroscopic and electrochemical measurements on 1 and its organic precursors 6-8 were

Hypoxia-activated NIR photosensitizer anchoring in the mitochondria for photodynamic therapy

Photodynamic therapy is considered as a promising treatment for cancer, but still faces several challenges. The hypoxic environment in solid tumors, imprecise tumor recognition and the lack of selectivity between normal and cancer cells extremely hinder t

Iodinated xanthene-cyanine NIR dyes as potential photosensitizers for antimicrobial photodynamic therapy

Photosensitizers (PSs) are chemical entities that upon light exposure are able to produce cytotoxic species such as singlet oxygen superoxide and free radicals. PSs are used in photodynamic therapy applications (PDT) to eradicate cancer cells, pathogenic bacteria, fungi, and viruses. Development of the NIR-activatable photosensitizes with high phototoxicity and low toxicity in dark conditions is challenging. Here we first report on the synthesis and antimicrobial testing of the new NIR photosensitizers based on the iodinated xanthene-cyanine dyes. These new photosensitizers exhibit high antimicrobial efficacy on Staphylococcus aureus pathogens at low dye concentration (~0.5 μM) and low NIR light dose (24.3 J/cm2).

Photodynamic therapy with tumor cell discrimination through rna-targeting ability of photosensitizer

Photodynamic therapy (PDT) represents an effective treatment to cure cancer. The targeting ability of the photosensitizer is of utmost importance. Photosensitizers that discriminate cancer cells can avoid the killing of normal cells and improve PDT effica

Bioorthogonally Applicable Fluorogenic Cyanine-Tetrazines for No-Wash Super-Resolution Imaging

The synthesis, fluorogenic characterization, and labeling application of four tetrazine-quenched cyanine probes with emission maxima in the red-far red range is reported. Fluorescence of the cyanine-cores is quenched via through-bond-energy-transfer (TBET) exerted by a bioorthogonal tetrazine unit. Upon bioorthogonal labeling reaction with cyclooctyne tagged proteins, the quenching effect ceases, and thus the fluorescence reinstates, resulting in an increase in fluorescence intensity. As a rare example among indocyanines, one of our new probes was found suitable in STED-based super-resolution imaging. The applicability of this fluorogenic Tet-Cy3 probe was therefore further demonstrated in the bioorthogonal labeling of cytoskeletal protein, actin, with subsequent super-resolution microscopy (STED) imaging even under no-wash conditions.

Iodinated cyanine dyes: a new class of sensitisers for use in NIR activated photodynamic therapy (PDT)

A new class of iodinated cyanine dyes have been prepared for use in NIR excited photodynamic therapy (PDT) and demonstrated improved efficacy in two pancreatic cell lines as well as excellent tumour control in a murine model of the disease.

MICROBUBBLE-CHEMOTHERAPEUTIC AGENT COMPLEX FOR SONODYNAMIC THERAPY

The invention relates to methods of sonodynamic therapy comprising the co-administration of a microbubble-chemotherapeutic agent complex together with a microbubble-sonosensitiser complex. It further relates to pharmaceutical compositions comprising these